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Cellular differentiation is accompanied by dramatic changes in chromatin 
structure which are associated with the activation of lineage-specific transcriptional 
programs. Facilitates Chromatin Transcription (FACT) is a histone chaperone 
complex which is important for chromatin-associated processes such as transcription, 
DNA replication and DNA repair. However, the role of FACT during differentiation of 
undifferentiated or stem-cell like cells has not yet been elucidated. We investigated 
the role of the FACT component Structure Specific Recognition Protein 1 (SSRP1) in 
adipocyte and osteoblast differentiation. Depletion of SSRP1 in human 
mesenchymal stem cells (hMSC) elicited lineage-specific effects where the 
adipocyte-specific genes PPARG, RASD1 and PDK4 were significantly increased 
while markers of osteoblast differentiation markedly decreased. Consistently, Oil Red 
O staining was increased during adipocyte differentiation while alkaline phosphatase 
staining was decreased in osteoblast differentiation following knockdown of SSRP1.  
Osteoblast differentiation plays a pivotal role in maintenance of bone 
homeostasis important for different bone-associated diseases including age-related 
bone loss. Thus this study was further focused on the molecular regulation of 
SSRP1-mediated effects on osteoblast differentiation. Transcriptome-wide RNA-seq 
revealed a specific enrichment of down-regulation of the canonical Wnt signaling 
pathway following SSRP1 depletion in osteoblasts. Furthermore a number of 
biological processes important for osteoblast differentiation including glycosylation, 
cell-cell contact, adhesion, extra cellular matrix, ossification, osteoblast differentiation, 
bone and skeletal development were affected by SSRP1 knockdown. In addition a 
significant nuclear co-localization of SSRP1 and β-catenin was observed where 
depletion of SSRP1 diminished accumulation of active β-catenin in the nucleus. 
Together, our data suggest a previously unknown specific role for SSRP1 in 
promoting the activation of canonical Wnt signaling during lineage-specific 
differentiation. 





1.1 Chromatin organization 
The genomic DNA in the nucleus of an eukaryotic cell is packaged into a 
highly ordered chromatin structure (Tremethick, 2007). The basic unit of chromatin is 
the nucleosome containing approximately 147 bp of DNA wrapped around an 
octamer containing two of each of histones H2A, H2B, H3 and H4. The histones H3 
and H4 form a tetramer (H3-H4)2 whereas H2A and H2B present as a dimer. 
Condensation into polynucleosomal arrays is aided by the peripheral linker histone 
H1 and other nucleosome-associated factors, including histone chaperones 
(McBryant et al., 2010; Tremethick, 2007; Williams and Tyler, 2007; Woodcock and 
Ghosh, 2010) (Figure 1). This compact architecture of chromatin provides a 
fundamental barrier to restrict the normal cellular processes such as gene 
expression, DNA repair and DNA replication. This barrier could affect the 
transcription machinery in two levels. (i) RNA polymerase cannot pass through the 
template strand of DNA, which requires an open chromatin; (ii) it restricts the access 
of transcriptional activators and general transcription machineries to their specific 
DNA sequences within the upstream regulatory region and core promoter (Oike et al., 
2014). Thus it is necessary to open or disassemble the chromatin during 
transcription with the equal importance to close it back or reassemble once the 
required process is done. Growing evidence suggest that epigenetic mechanisms 
play an essential role in regulating chromatin dynamics by two distinct ways: using 
histone modifications and chromatin remodeling (Berger, 2007). 
N-terminal and C-terminal tails of the individual histones are subjected to a 
wide range of post-translational covalent modifications, including acetylation, 
phosphorylation, methylation, monoubiquitination, sumoylation, formylation, 
crotonylation, ADP ribosylation and so on. These play a pivotal role in controlling 
chromatin remodeling and regulating gene transcription (Bernstein et al., 2007; 
Campos and Reinberg, 2009; Clapier and Cairns, 2009; Jenuwein and Allis, 2001; 
Kouzarides, 2007; Weake and Workman, 2008; Workman and Kingston, 1998). 
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of chromatin (Clapier and Cairns, 2009; Ransom et al., 2010). The highly acidic 
nature of histone chaperone proteins allow them bind directly to the basic histones 
and aid in directing histone deposition, exchange and eviction during nucleosome 
assembly and disassembly (Akey and Luger, 2003; Eitoku et al., 2008; Park and 
Luger, 2008).  
1.2 Histone chaperones: Modulators of chromatin architecture 
Since the complex higher order structure of chromatin provides a fundamental 
barrier to the different DNA-associated processes including transcription, replication, 
recombination and DNA damage responses, it is critical to modulate the chromatin 
structure for proper cellular growth, differentiation and development. Several 
regulators which play key role in dynamic remodeling of the chromatin structure are 
histone modifiers, histone variants, chromatin remodelers and histone chaperones. 
Moreover studies also showed the interplay between these key regulators which 
ultimately lead to the more dynamicity in the accessibility of the chromatin 
(Avvakumov et al., 2011; Niederacher et al., 2011; Venkatesh and Workman, 2015).  
Histone chaperones are histone-interacting proteins which are involved in the 
storage, transport, nucleosomal assembly and disassembly of the histones thus 
modulating the architecture of the chromatin (D’Arcy et al., 2013; de Koning et al., 
2007; Venkatesh and Workman, 2015). They usually bind to the non-chromatinized 
histones, crucial for nucleosome formation. The association of histones with their 
chaperones could prevent the histone from non-specific binding to nucleic acids and 
other proteins. Moreover, it could also stabilize the histone oligomers in the free and 
soluble state outside of the nucleosomes (Burgess and Zhang, 2013; Elsässer and 
D’Arcy, 2013). The specificity in binding of histone chaperones to histones differs. 
Some of the histone chaperones can bind to H2A-H2B whereas others are specific 
to H3-H4. Nucleosome-Assembly Protein 1 (Nap1) can bind to H2A-H2B dimer in the 
cytoplasm, shuttle them into the nucleus which then can assemble into the 
nucleosome (Miyaji-Yamaguchi et al., 2003; Mosammaparast et al., 2002). The 
histone chaperones Anti-Silencing Function 1 (ASF1) and the Chromatin Assembly 
Factor 1 (CAF1) can deposit H3-H4 tetramers during replication (Winkler et al., 
2012). Interestingly a single histone chaperone can bind to all the histones, for 
example Facilitates Chromatin Transcription (FACT). Moreover, some histone 




chaperones such as CAF1 and HIRA are highly specific to histone variants H3.1 and 
H3.3 respectively (Tagami et al., 2004).  Suppressor of Ty Homolog 6 (SUPT6H) and 
FACT modulate nucleosomal remodeling during transcription (Duina, 2011).  
Unlike ATP-dependent chromatin remodelers histone chaperones destabilize 
the chromatin by using spontaneous DNA movement around the dyad axis (Hondele 
et al., 2013). Number of studies also showed the cooperation between the histone 
chaperones and different chromatin remodelers for the dynamic remodeling of 
chromatin structure (Kuryan et al., 2012; Lorch et al., 2006; Swaminathan et al., 
2005). 
Histone chaperones also play an important role in transcription specific 
histone post translational modifications. H3K56 acetylation is mediated by Regulator 
of Ty1 Transposition 109 (Rtt 109) which is important for histone exchange and 
subsequent transcription initiation and elongation in yeast (Schneider et al., 2006). 
However, Rtt 109 can not directly acetylate H3K56 within the nucleosome. It needs 
the assistance of the histone chaperone ASF1 which presents H3K56 in a structural 
conformation favorable for the effective acetylation (Kolonko et al., 2010; Tsubota et 
al., 2007). Another well studied example is the trimethylation of H3K36 mediated by 
the histone methyltransferase SET2. Importantly, the histone chaperone Spt6 is 
required to make different regions of the nucleosome accessible for this 
trimethylation (Du and Briggs, 2010; Du et al., 2008). 
1.2.1 The histone chaperone FACT 
The human FACT complex is a heterodimeric protein composed of two 
subunits: Structure Specific Recognition Protein 1 (SSRP1) and Suppressor of Ty 
Homolog 16  (SUPT16H) (Orphanides et al., 1998, 1999; Reinberg and Sims, 2006). 
In yeast the homolog of SSRP1 is known as Pob3-Nhp6. This is a highly conserved 
histone chaperone among eukaryotes which has been shown to play roles in 
overcoming chromatin barriers during transcription and replication and is also 
important for assembling and maintaining nucleosomes (Brewster et al., 1998, 2001; 
Wittmeyer and Formosa, 1997). Initially, FACT was identified as a factor which 
allows RNA Polymerase (RNAP II) to passage through the DNA template during 
transcription elongation, thus named as “facilitates chromatin transcription” 




(Orphanides et al., 1998, 1999; Reinberg and Sims, 2006). Moreover,  FACT is 
essential for the viability of a range of organisms including yeast and mice (Formosa, 
2008; Lejeune et al., 2007; Van Lijsebettens and Grasser, 2010; Winkler and Luger, 
2011).  
1.2.1.1 Structure of FACT complex 
SUPT16H/Spt16 
SUPT16H contains four domains termed as N-terminal domain (NTD), the 
dimerization domain (DD), the middle domain (MD), and C-terminal domain (CTD) 
(Figure 2) (Keller and Lu, 2002; Tsunaka et al., 2009; VanDemark et al., 2006). The 
NTD of SUPT16H is a highly conserved domain across several species. Interestingly, 
NTD was shown to be nonessential for yeast viability as well as nucleosome binding 
(O’Donnell et al., 2004; Stuwe et al., 2008; VanDemark et al., 2008). Moreover, the 
NTD of yest Spt16 displays an aminopeptidase-like “pita bread” fold. However, no 
peptidase activity has been detected in Spt16 or FACT due to the missing critical 
peptidase active site residues (Stuwe et al., 2008; VanDemark et al., 2008). The 
NTD of Spt16 is capable of specific binding to H3 and H4 N-terminal tails but not with 
H2A-H2B dimer (Stuwe et al., 2008). However, the proteolytic hydrolysis of all 
histone tails significantly affected the affinity of FACT complex to nucleosome (Stuwe 
et al., 2008; VanDemark et al., 2008) indicating the crucial importance of the NTD of 
Spt16 as a binding partner of  the histone tails. One study reported that the NTD of 
Spt16 from S. Pombe did not show binding to H3-H4 N-terminal tails, rather higher 
binding affinity was reported to H4 tail only (Stuwe et al., 2008). Interestingly in yeast, 
a functional interaction was found between Spt16 NTD and the C-terminal docking 
domain extension of H2A (VanDemark et al., 2008). Thus it appears that the Spt16 
NTD has different affinities to each histone which could lead to the nucleosomal 
reorganization through the destabilization of dimer-tetramer interaction.   
The DD of SUPT16H is implicated in the heterodimerization with SSRP1 
(Keller and Lu, 2002). This domain is suggested to be partially unfolded in 
metazoans and yeast, which is stabilized by the neighboring middle domain. Notably, 
the middle domain of both SUPT16H/Spt16 and SSRP1/Pob3 shares some 
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features of CTD in human SUPT16H is that it binds to the H2A-H2B dimers 
(Belotserkovskaya et al., 2003).   
SSRP1/Pob3-Nhp6 
The human SSRP1 consists of five domains which are NTD/DD, MD, 
Intrinsically Disordered Domain (IDD), High Mobility Group 1(HMG-1) and C-terminal 
Intrinsically Disordered Domain (CID) (Figure 2) (Tsunaka et al., 2009; VanDemark 
et al., 2006). 
The yeast homolog of SSRP1 has two  proteins in a complex namely Pob3 
and HMG domain containing protein Non-Histone Protein 6 (Nhp6) (Brewster et al., 
2001).  The Pob3 protein has some structural similarities with SSRP1 by containing 
the NTD/DD, MD and an intrinsically disordered CTD (VanDemark et al., 2006). The 
SSRP1/Pob3 NTD has been implicated in the heterodimerization with the DD of 
SUPT16H/Spt16 (Keller and Lu, 2002; O’Donnell et al., 2004). Moreover the first 111 
of 220 residues in Pob3 NTD/DD contins a single pleckstrin homology (PH) domain 
which is characterized by a range of ligand binding properties including proteins or 
small peptides and lipids as well (VanDemark et al., 2006; Winkler and Luger, 2011).  
The middle domain of Pob3 is also a well characterized domain which has 
double PH domain termed as PH1 and PH2, both of which are homologous to the 
PH domain of Pob3 NTD/DD. However, PH2 of Pob3 MD is more similar to Pob3 
NTD/DD compared to PH1 (VanDemark et al., 2006). Moreover, Spt16 MD also 
contains a tandem PH domain which is similar in sequence with Pob3 MD (Winkler 
and Luger, 2011). The Spt16 MD was also reported to bind to the H3-H4 histones in 
addition to H2A-H2B binding, whereas Pob3 MD can bind only to H3-H4 histones 
(Formosa, 2012; Winkler and Luger, 2011; Yang et al., 2016). Interestingly, a recent 
report showed the DNA binding properties of Pob3 MD. In human and other higher 
eukaryotes, SSRP1 contains a C-terminal HMG-1 domain which has the significant 
binding affinity to DNA. However, in yeast, the HMG-1 domain represented as a 
separate protein called Nhp6a/b. This domain assists the FACT to recognize DNA in 
nucleosome and thus helps in the positioning and reorganization of the chromatin 
(Yang et al., 2016). Moreover there are two intrinsically disordered domains (CID) in 
SSRP1, whose function remains elusive. Interestingly, a very recent study reported 




the CTD of Pob3 which has similarity with the CID of SSRP1 that can bind to H2A 
and H2B  (Hoffmann and Neumann, 2015).    
1.2.2 Function of FACT complex in chromatin remodeling 
The FACT complex is well established in their role in reorganizing chromatin 
structure to make it more accessible. Currently there are two models available to 
explain the action of FACT on chromatin remodeling termed “dimer eviction” and 
“global accessibility” model (Figure 3).   
In the dimer eviction model, the FACT complex binds to the surface of DNA in 
a canonical nucleosome, thus leading to the bending of DNA. Binding and bending of 
DNA thus results in a more open and less stable nucleosome which is then 
reorganized by the FACT components through the disruption of the nucleosome due 
to the dissociation of a single H2A-H2B dimer. Here a hexasome of histones 
containing a H3-H4 tetramer and a H2A-H2B monomer is left on the DNA. 
Furthermore, the histone components are tethered in a way so that they are not lost 
from comparatively open form of chromatin (Belotserkovskaya et al., 2003; 
Orphanides et al., 1999; Reinberg and Sims, 2006).  In the global accessibility model, 
the nucleosome is represented already in an equilibrium state between the canonical 
and the less stable reorganized form. Then, FACT can bind to the open state 
preferentially. According to the global accessibility model, binding of FACT to the 
relatively open state can prolong the duration of the accessibility of the chromatin in 
the reorganized and less stable state (Formosa, 2008; Xin et al., 2009). Both models 
were depicted based on the previous observations. For instance, when FACT 
components were incubated with immobilized nucleosome for one hour, around half 
of the H2A-H2B dimers were lost (Belotserkovskaya et al., 2003). In another study 
histones were crosslinked to prevent the H2A-H2B dimer expulsion which resulted in 
the ability of FACT to promote transcription (Orphanides et al., 1999). A study with 
single molecule Fluorescence Resonance Energy Transfer (FRET) experiments 
support the global accessibility model, where the nucleosome was found in an 
equilibrium state between the closed and a relatively opened state with the displaced 
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(Biswas et al., 2005). Consistently loss of Spt16 minimized TBP, TFIIB and PolII 
binding at the promoter region (Mason and Struhl, 2003). Moreover, FACT was 
reported to play an important role in the fidelity of transcription initiation (Mason and 
Struhl, 2003). Functional inactivation of Spt16 through conditional mutations led to 
the increased Pol II density, transcription and TBP occupancy at the 3' regions of 
some coding genes, which suggests the role of FACT to prevent cryptic 
transcription(Carvalho et al., 2013). Furthermore Nhp6 was reported to promote TBP 
binding to RNAP II. Nhp6 also displayed involvement during transcriptional initiation 
through Pol III. Another histone chaperone ASF1 was demonstrated to bind in the 
upstream of HO promoter along with yeast FACT (Takahata et al., 2009).  
1.2.3.2 FACT in transcription elongation 
The role of FACT in DNA transcription elongation is well established. FACT 
was initially purified as a factor being capable of promoting RNAP II elongation 
through nucleosomes (Orphanides et al., 1998). Later more evidences supported the 
direct participation of FACT in elongation(Belotserkovskaya et al., 2003; Hsieh et al., 
2013; Orphanides et al., 1999; Wada et al., 2000). FACT was also showed to be 
interacting with a number of transcription elongation factors. For example, the yeast 
FACT subunits Spt16 and Pob3 were shown to interact with Spt4, Spt5, Spt6 and 
polymerase associated factor 1 (Paf1) complex (Krogan et al., 2002; Lindstrom and 
Hartzog, 2001; Lindstrom et al., 2003; Sims et al., 2004; Squazzo et al., 2002). In 
addition, a Chromodomain Helicase DNA Binding Protein 1 (CHD1) also showed 
interactions with FACT both in mammalian cells and yeast (Krogan et al., 2002; 
Simic et al., 2003). In yeast, Chd1 is recruited to the open reading frame along with 
FACT and several other elongation factors. Specifically SSRP1 was reported for its 
colocalization and interaction with CHD1 (Kelley et al., 1999). After transcription 
initiation RNAP II pauses or stops transcribing at 15 to 45 nucleotides after TSS 
which is denoted as promoter proximal pausing of RNAP II. Interestingly, FACT 
promotes the release of pause 45 nucleotide position by disrupting the H3-H4:DNA 
contacts (Hsieh et al., 2010, 2013; Ujvári et al., 2008).  
Studies suggest that FACT is recruited to the transcription complex by other 
transcription factors. Now the question comes how FACT is recruited to transcription 
machineries. Since FACT interacts with a number of general transcription factors 




including TFIIE, TFIIH, it is possible that FACT can have an indirect interaction with 
RNAPII (Belotserkovskaya et al., 2004; Lindstrom and Hartzog, 2001; Squazzo et al., 
2002). Moreover, FACT can also bind to single stranded DNA which is generated 
during transcription (Belotserkovskaya et al., 2004). Pavri et al., (2006) showed an 
interesting finding about the role of FACT in transcription where they reported a 
functional interaction between FACT, PAF and H2B monoubiquitination (H2Bub1) 
which represents active transcription elongation. They showed that H2B 
monoubiquitination by the E3 ubiquitin ligase RNF20/RNF40 facilitates the function 
of FACT to evict H2A-H2B dimer thus disrupt H2A-H2B:DNA contacts and as a 
consequence RNAP II get access to DNA (Pavri et al., 2006).  
1.2.3.3 Fact in transcription termination 
The role of FACT in transcription termination is not well understood. FACT 
and other transcription factors which run along with RNAP II have been found to 
dissociate at two distinct sites near to the 3' end indicating an ordered manner of 
termination (Mayer et al., 2010). Notably FACT becomes separated at the first 
dissociation site. When histone H3 was mutated there was an accumulation of FACT 
and RNAP II at this site (Duina et al., 2007; Lloyd et al., 2009; Myers et al., 2011). 
Moreover FACT can have an interaction with H3, but the role of this interaction in 
transcription is yet to be elucidated.  
1.2.4 Regulation of FACT 
 
The FACT complex was shown for its potential effects in regulating several 
factors involved in different DNA-associated processes including replication, 
transcription, repair and recombination. However, FACT complex can also be 
regulated by other factors. Phosphorylation of Spt16 restricts FACT to bind to the 
nucleosome in response to genotoxic stress (Huang et al., 2006). Phosphorylation of 
SSRP1 by Casein Kinase 2 (CK2) affects its nucleosomal DNA binding (Keller and 
Lu, 2002; Keller et al., 2001). FACT can also undergo to the post-translational 
modifications which further regulates its activity. In yeast, Spt16 can be ubiquitinated 
by the E3 ubiquitin ligase Rtt101 which assist its recruitment into the origin of 
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1.3 Bone  
Bone is a highly specialized connective tissue with the extraordinary capacity 
for growth, regeneration, and remodeling throughout life. Bone consists of organic 
extracellular matrix hardened by the inorganic minerals. The regions between the 
organic and inorganic portions are filled with two main types of components: (i) the 
outer hard cortex and (ii) the inner spongy like substances (Clarke, 2008). Bone 
performs several crucial functions comprise: (i) structural and mechanical support to 
the body, (ii) protects the vital inner organs, (iii) key component in the locomotive 
system, (iv) maintains the mineral homeostasis, and  (v) primary sites for the 
formation of blood cells (Lee et al., 2007; Long, 2012).  
1.3.1 Bone cells 
The bone contains three major types of cells. These are osteoblasts, 
osteocytes and osteoclasts which are responsible for production, maintenance, and 
resorption of bone respectively (Figure 5) (Clarke, 2008; Sims and Martin, 2014). 
Osteoblasts, the chief bone forming cells are originated from a common progenitor 
cell with adipocytes, bone marrow derived mesenchymal stem cells (MSCs). The 
sequential process of new bone formation involves (i) recruitment of osteoblasts 
precursor to the site of osteoid deposition, (ii) precursors start differentiating towards 
osteoblasts, (iii) synthesizing first the organic matrix (i.e. the osteoid) and (iv) 
contributing to its mineralization. After all these processes are accomplished, the 
majority of osteoblasts enter into apoptosis. The rest of the cells are entrapped in the 
mineralized extra cellular matrix (ECM) as terminally differentiated mature 
osteoblasts which are termed as osteocytes. A part of the survived cells can also 
reside in the covering of the bone surface as bone-lining cells (Bonewald, 2011; 
Bonewald and Dallas, 1994; Imai et al., 1998). 
Osteoclasts are multinucleated cells which originate from the hematopoietic 
stem cell precursor along the myeloid differentiation lineage. These cells are mainly 
responsible for the degradation of bone. During the process of bone resorption 
osteoclasts attach to the bone surface, isolate the area, cause acidification and 
finally disperse the inorganic ECM. Different proteases also come into action to 
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for this specific lineage fate. Overall osteoblast differentiation can be discussed in 
the following points (Figure 6). 
(I) Lineage commitment: This is the very first step where MSCs become 
committed to be differentiated into osteoblast. The committed cells are 
called osteoprogenitors. There is very limited knowledge about the 
circumstances that induce osteoblast lineage commitment from the 
multipotent stem cells. Even there is not much difference between MSCs 
and osteoprogenitors (Franceschi, 1999). However, several transcription 
factors and mediators start their action here including RUNX2 and SP7, 
DLX5 and MSX2 (Ducy et al., 1997; Komori, 2006; Komori et al., 1997; 
Nakashima et al., 2002a; Otto et al., 1997).    
(II) Proliferation and matrix formation: In the next phase osteoprogenitors are 
developed into pre-osteoblasts. ECM synthesis also begins in this step. 
Important feature of this step is to express collagen type 1 (COL1A1) and 
bone sialoprotein (IBSP). Still RUNX2 and SP7 are expressed (Delorme et 
al., 2009).  
(III) Matrix maturation and mineralization: Pre-osteoblasts are then 
differentiated into mature osteoblasts with the enhanced expression of 
ALPL. The ECM also matures in this step to make contact with the 
neighboring cells. Importantly mineralization also happens during this step 
(Aubin, 2001; Choi et al., 2010; Traianedes et al., 1993). 
(IV) Mature bone tissue: Last stage of bone formation. A subset of mature 
osteoblasts is entombed within the bone matrix to form osteocytes. A 
portion also resides on the surface as inactive bone-lining cells. The rest of 
the matured osteoblasts undergo programmed cell death (Bonewald, 
2011). In mammalian bone, osteocytes are the most abundant cellular 
component accounting for 95% of total cells. As terminally differentiated 
cells, osteocytes play a vital role in mediating communication with 
neighboring cells, translating mechanical stimuli to the biochemical signals 
for formation or resorption of bone. Recently their endocrine functions 
have also been reported expressing fibroblast like growth factor 23 and 
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factor in regulation of osteoblast differentiation. Homozygous deletion of RUNX2 in 
mice resulted in complete loss of osteoblast activity (Komori et al., 1997; Otto et al., 
1997). Moreover deletion of RUNX2 carboxy terminal domain responsible for nuclear 
targeting signal resulted in the identical RUNX2-null mice phenotype (Choi et al., 
2001). Additionally RUNX2 was reported to be essential for induction of the major 
bone matrix related genes (Ducy et al., 1999). Interestingly most of the osteoblast 
differentiation related signaling pathways are targeted at RUNX2 (Komori, 2006). 
However RUNX2 is the early expressed gene which gradually decreases with the 
maturation of osteoblasts while other genes come into action such as osterix (SP7) 
and β-catenin (Komori, 2006, 2010; Maruyama et al., 2007; Nakashima et al., 2002b). 
SP7 is another important transcription factor essential for proper osteoblast 
differentiation. Deletion of SP7 resulted in the complete lack of osteoblasts in mouse 
embryos. Importantly SP7 was reported downstream to RUNX2 as deletion of 
RUNX2 also abolished SP7 (Nakashima et al., 2002b).  
Other transcription factors have been found to be crucial for osteoblast 
differentiation include activating transcription factor 4 (ATF4) and activator protein 1 
(AP1) family (Wagner, 2002; Yu et al., 2005). ATF4 is a member of the basic 
Leucine zipper (bZIP) family of transcription factors which plays important roles in 
mature osteoblasts. Misregulation of ATF4 activity has been linked with the skeletal 
abnormalities (Elefteriou et al., 2006; Yang et al., 2004). AP1 family members also 
have been shown to affect the osteoblast differentiation and bone formation (Eferl et 
al., 2004; Wagner, 2002). 
1.3.3.2 Regulation by signaling pathways 
Several signaling pathways have been implicated in the tight regulation of 
osteoblast differentiation. Among them Wnt signaling has emerged as one of the 
major pathways in regulating osteoblastogenesis, bone and skeletal development. It 
also plays important role in bone formation and resorption.  
Wnt-signaling occurs in three different ways; i) Canonical or Wnt β-catenin 
pathway ii) Non canonical and iii) Wnt-calcium pathway (Baron and Kneissel, 2013). 
Among these, the canonical pathway has emerged as one of the important 
regulators of bone homeostasis. In the canonical pathway, when there is no 




stimulation, β-catenin resides in the inactive complex along with GSK-3β, AXIN, and 
APC which later become phosphorylated by GSK-3β and thus targeted for 
polyubiquitination by proteasome-mediated degradation. In response to appropriate 
stimuli Wnt ligands bind to the receptor [Frizzled (Fzd) and either Low-density 
lipoprotein receptor-related proteins (LRP5 or LRP6)]; β-catenin becomes activated 
by coming out of the inactive complex. The activated β-catenin then translocate into 
the nucleus where they bind to the T-cell factor/lymphoid enhancer factor (TCF/LEF) 
transcription factor, thus activate expression of the genes required for bone 
formation. Wnt signaling can be controlled in different stages of the pathway. For 
example different Wnt ligands such as Wnt2, Wnt3a, Wnt 11, Wnt 10b etc. can 
induce the activation whereas Wnt antagonists such as DKK/Kremen can inhibit the 
pathway (MacDonald et al., 2009; Yavropoulou and Yovos, 2007). The 
phosphorylation of β-catenin can be blocked by the cytoplasmic protein Dishevelled 
(Dsh) which inhibits GSK-3β in response to the Wnt ligands binding to the receptors 
such as FZD, LRP5 or LRP6 (van Amerongen and Nusse, 2009; Baron and Kneissel, 
2013; Kikuchi et al., 2009; Kohn and Moon, 2005). 
Studies showed that activation of the Wnt-signaling by the canonical Wnt ligand 
Wnt10b or inhibition of GSK-3β activity enhanced osteoblast differentiation (Bennett 
et al., 2005, 2007). Moreover stimulation of the canonical Wnt-signaling through 
Wnt3a-LRP5 activation led to the increased ALPL expression and decreased lipid 
droplet formation in hMSC. Conversely these effects were reversed when LRP5 was 
inactivated (Qiu et al., 2007). Similar results regarding LRP5 activity were also 
observed in vivo systems. A high bone mass or increased trabecular bone volume 
and decreased fat within the marrow were observed as a consequence of gain of 
mutations in LRP5 in humans (Boyden et al., 2002; Little et al., 2002; Qiu et al., 
2007). An opposite phenomena was observed in response to the loss of functions in 
LRP5 which promoted osteoporosis characterized by the decreased bone and 
increased intramedullary fat (Gong et al., 2001; Qiu et al., 2007). 
Beside canonical Wnt signaling, noncanonical pathway has also been 
reported for regulation of bone formation and development (Baron and Kneissel, 
2013). Noncanonical ligand WNT7b was reported to stimulate osteoblast 
differentiation through G protein–linked protein kinase C δ (PKC-δ) signaling (Tu et 




al., 2007). Another ligand Wnt5a can induce osteoblast differentiation over adipocyte 
differentiation (Takada et al., 2007). Wnt Inhibitory Factor 1 (WIF 1) can inhibit 
osteoblast differentiation (Cho et al., 2009). Moreover, activation of noncanonical 
receptor ROR1 and ROR2 can induce bone formation and skeletogenesis (Maeda et 
al., 2012). Interestingly some components of the Wnt signaling can control both 
canonical and noncanonical pathway. These include RSPO1, SFRP1, SFRP2, 
SFRP4 (Baron and Kneissel, 2013). 
Apart from Wnt signaling other important signaling pathways involved in 
regulation of osteoblast differentiation and bone formation include TGF-β, BMP, 
Notch, Hedgehog, and Fibroblast Growth Factors (FGF). These pathways have been 
shown to act independently as well as to interact with each other for the complex 
regulation of osteoblast differentiation, bone and skeletal development (Guo and 
Wang, 2009; Lin and Hankenson, 2011; Rahman et al., 2015).  
1.3.3.3 Epigenetic regulation of osteoblast differentiation 
Epigenetic mechanisms bring changes in gene expression due to the 
modifications on DNA and chromatin without alteration in DNA sequences. The 
orchestrated regulation of gene expression during differentiation requires a complex 
interplay between transcription factors and epigenetic mechanisms which together 
direct lineage-specific gene expression (Håkelien et al., 2014). Epigenetic 
mechanisms including post-translational histone modifications, DNA methylation and 
changes in chromatin structure by chromatin remodelers and histone chaperones, 
are required for the proper regulation of gene expression during osteoblast 
differentiation (Gordon et al., 2015; Hemming et al., 2014; Karpiuk et al., 2012; Wei 
et al., 2011).  
Acetylation and methylation are the most well studied post-translational 
histone modifications in osteoblast differentiation and bone development. 
Methylation of histones at specific position can activate or repress osteoblast 
differentiation. H3K4 trimethylation or H3K36 methylations were reported to be the 
active marks whereas H3K27 trimethylation act as an inactive mark for osteoblast 
differentiation (Hassan et al., 2007, 2009; Lee et al., 2014; Leventopoulos et al., 




2009). Moreover a number of demethylases can demethylate the histones thus 
altering their role in regulation of osteoblast differentiation.  
In addition to histone methylation, acetylation and deacetylation of histones 
have also been demonstrated to be important in the regulation of osteogenic genes. 
Several histone acetyltransferases such as p300, CBP, PCAF were implicated as a 
direct or co-regulator of a number of bone-related genes including RUNX2 through 
histone acetylation (Sierra et al., 2003). Both promoter and coding region of BGLAP 
gene was found to be enriched in H3 and H4 acetylated marks during the 
proliferative period of osteoblast differentiation (Montecino et al., 1999; Shen et al., 
2003). Interestingly, histone acetylation is often associated with a comparatively 
open chromatin and active transcriptional state while histone deacetylation is 
involved with chromatin condensation and gene silencing. 
Apart from the post-translational histone modifications, DNA methylation is an 
important epigenetic regulator for osteoblast differentiation. Notably significant 
hypermethylation is associated with chromatin condensation which can repress the 
gene expressions (Villagra et al., 2002). Methylation at the ALPL gene was found to 
be a major regulator for controlling its expression. Evidences came from the DNA 
demethylating agents, while used increased the significant expression of ALPL 
during osteoblast differentiation in osteogenic and non-osteogenic condition. 
Accordingly, very low level of methylation was found in ALPL expressing osteoblasts 
while in osteoclast it was found in hypermethylated state (Delgado-Calle et al., 2011; 
El-Serafi et al., 2011; Locklin et al., 1998; Vaes et al., 2010). The changes in 
methylation status was also observed in osteocalcin gene during osteoblast 
differentiation in response to stimulation of differentiation (Arnsdorf et al., 2010; 
Villagra et al., 2002). The other osteoblast differentiation marker genes whose 
regulation is also changed due the methylation are OPG, OPN, OSX etc (Arnsdorf et 
al., 2010; Delgado-Calle and Riancho, 2012; Lee et al., 2006). 
1.4 Role of histone chaperones in cellular differentiation 
Histone chaperones are the proteins having the abilities to execute 
nucleosome reorganization which could play crucial role during cellular differentiation. 
Importantly studies have been carried out to elucidate the role of histone chaperones 




in stem cell differentiation to specific lineages. Some examples have been listed 
below:  
 The histone chaperones HIRA and ASF1 showed specific functions during 
osteoblast and myoblast differentiation from C2C12 cells. Both of the histone 
chaperones were maintained throughout the differentiation stages for 
myoblast differentiation whereas they were diminished half or more during 
osteoblast differentiation (Song et al., 2012b). Two previous studies also 
reported the importance of HIRA and ASF1 in myoblast differentiation were 
mediated by the regulation of master regulator MyoD and Mef2 expression 
(Yang et al., 2011, 2011).  
 Histone chaperone SUPT6H was found to play important role during 
myogenesis by assisting in the removal of repressive epigenetic mark 
H3K27me3. SUPT6H could facilitate the proper engagement of demethylase 
KDM6A (UTX), which in turn mediated demethylation of H3K27me3, thus 
activated the expression of muscle genes including the key myoblast specific 
gene MyoD (Wang et al., 2013).  
A connection between H2Bub1 and SUPT6H in regulating osteoblast and 
adipocyte differentiation from hMSC was reported by Bedi et al., (2014). 
Knockdown of SUPT6H decreased the level of H2Bub1 and also negatively 
affected osteoblast and adipocyte differentiation, depicting the crucial role of 
SUPT6H in hMSC differentiation which could be partly mediated by H2Bub1 
(Bedi et al., 2015).  Consistently, the role of H2Bub1 in cellular differentiation 
of hMSC was demonstrated by a previous study (Karpiuk et al., 2012). 
 CHAF1A is another histone chaperone was reported to inhibit neuronal 
differentiation and to promote aggressive neuroblastoma with the overall poor 
prognosis by regulating H3K9me3 (Barbieri et al., 2014).  
Above discussion shows a clear connection between the histone chaperones, their 
role in chromatin modifications and consequences in the regulation of cellular 
differentiation. 
 




1.5 Aim of the study 
Several studies have shown the pivotal role of the histone chaperone FACT in 
different DNA-associated processes including transcription, replication, DNA repair 
and recombination. Higher expression of FACT components was reported in 
undifferentiated or poorly differentiated cells, stem cells or stem cell-like cells 
whereas the adult mammalian tissues contain very low level of FACT. However the 
core functions of FACT components during differentiation are largely unknown. We 
hypothesized that FACT components play an important role in cellular differentiation 
of multipotent stem cells. Specifically we aimed to investigate the role of the FACT 
component SSRP1 in adipocyte and osteoblast differentiation considering the 
significant reciprocal balance of these two cellular fates in development process. To 
address this hypothesis we depleted SSRP1 in hMSCs and examined the influence 
on differentiation potency. Considering the importance of osteoblast differentiation in 
bone homeostasis, we further aimed to extend the study to osteoblast differentiation. 
High-throughput RNA sequencing in human Fetal Osteoblast (hFOB) was used to 
identify the transcriptome-wide effects of SSRP1 on osteoblast differentiation. In 
addition dual luciferase reporter assays was used to test the role of SSRP1 in Wnt-

















2.1 Technical equipment 
Agarose gel chamber Harnischmacher Labortechnik, Kassel 
Balance Sartorius AG, Göttingen 
Bandelin Sonoplus Sonicator Bandelin electr. GmbH & Co. KG, Berlin 
Biological Safety Cabinet “Hera Safe” Thermo Fisher Scientific, Waltham, USA 
Bioruptor Diagenode, Belgium, Europe 
Centrifuge (Megafuge 1.OR) Thermo Fisher Scientific, Waltham, USA 
Centrifuge 4°C (5417R) Eppendorf AG, Hamburg 
Centrifuge 4°C (Fesco 21) Thermo Fisher Scientific, Waltham, USA 
C1000TM Thermal Cycler Bio-Rad Laboratories GmbH, München 
CFX96TM Optical Reaction Module Bio-Rad Laboratories GmbH, München 
Counting chamber (Neubauer) Brand GmbH & Co. KG, Wertheim 
Confocal microscope LSM510 META Carl Zeiss MicroImaging GmbH, 
Göttingen 
5100 Cryo 1°C Freezing Container Thermo Fisher Scientific 
Electrophoresis & Electrotransfer Unit Bio-Rad Laboratories GmbH, München 
Freezer -20 °C Liebherr GmbH, Biberach 
Freezer -80 °C (Hera freezer) Thermo Fisher Scientific, Waltham, USA 
Freezer -150°C (MDF-C2156VAN) Panasonic, Kadoma, Japan 
Gel Imager “Gel iX imager” Intas Science Imaging GmbH, Göttingen 
Incubator (bacteria) Memmert GmbH & Co. KG, Schwabach 
Incubator (cell culture) “Hera cell 150“ Thermo Fisher Scientific, Waltham, USA 
Luminometer „Centro LB 960“ Berthold Technologies, Bad Wildbad 
Magnet stirrer “MR3001” Heidolph GmbH & Co. KG, Schwabach 
Microscope Axio Scope A1 Carl Zeiss MicroImaging GmbH, 
Göttingen 
Microscope “Axiovert 40 C“ Carl Zeiss MicroImaging GmbH, 
Göttingen 
Microwave Clatronic International GmbH, Kempen 
Nano Drop® ND-1000 
Spectrophotometer  
Peqlab Biotechnology GmbH, Erlangen 
OptiMax X-ray Processor Typon Medical, Krauchthal 
pH meter inoLab® WTW GmbH, Weilheim 
Pipette Aid® portable XP Drummond Scientific Co., Broomall, USA 
Pipettes “Research” Series Eppendorf AG, Hamburg 
Power supply “Power Pack P25T” Biometra GmbH, Göttingen Material 
Qubit® 2.0 Fluorometer Invitrogen GmbH, Karlsruhe 
Refrigerator Liebherr GmbH, Biberach 
Scanner Epson 1680 Seiko Epson, Suwa, Japan 
Shaker “Rocky” Schütt Labortechnik GmbH, Göttingen 
Table centrifuge (VWR Mini Star) Korea  
Test tube rotator Schütt Labortechnik GmbH, Göttingen 
Ultrapure Water System “Aquintus” MembraPure GmbH, Bodenheim 
Vacuum pump (BVC Control) Vacuubrand GmbH and Co. KG, 





Vortex-Genie 2 Electro Scientific Industr. Inc., Portland, 
USA 
X- Ray Cassettes Rego X-ray GmbH, Augsburg 
2.2 Consumable materials 
Cellstar 6-, 12-, 24-well cell culture 
plates 
Greiner Bio-One GmbH, Frickenhausen 
Cellstar PP-tube 15 and 50 ml Greiner Bio-One GmbH, Frickenhausen   
Cellstar tissue culture dish 100×20 mm Greiner Bio-One GmbH, Frickenhausen 
Cellstar tissue culture dish 145×20 mm Greiner Bio-One GmbH, Frickenhausen 
Cell scraper (16 cm, 25 cm) Sarstedt AG & Co., Nümbrecht 
Cryo TubeTM Vial (1.8 ml) Thermo Fisher Scientific, Waltham, USA  
Falcon® assay plate, 96 well VWR Int., LLC, West Chester, USA 
Gel blotting paper (Whatman paper) Sartorius AG, Göttingen 
Glass coverslips (18 mm) Gebr. Rettberg GmbH, Göttingen 
HybondTM-PVDF Transfer Membrane GE Healthcare Europe GmbH, München 
Microtube 0,5 ml, 1.5 ml, 2 ml Sarstedt AG & Co., Nümbrecht 
Microtube 1.5 ml, conical VWR International GmbH, Darmstadt 
96 Multiply® PCR plate white Sarstedt AG & Co., Nümbrecht 
96-well Multiplate PCR plate white (low) Bio-Rad Laboratories GmbH, München 
NORM-JECT Syringes of different 
volume 
Henke Sass Wolf GmbH, Tuttlingen 
Parafilm® “M” Pechiney Plastic Packaging, Chicago,  
USA 
Petri dish 92×16 mm Sarstedt AG & Co., Nümbrecht 
Pipette tips Greiner Bio-One GmbH, Frickenhausen 
Pipette filter tips Sarstedt AG & Co., Nümbrecht 
Protan® Nitrocellulose transfer 
membrane 
Whatman GmbH, Dassel 
Syringe filter, CA-membrane, 0,20 µm Sartorius AG, Göttingen 
Ultra low attachment plates Corning Life sciences, NY, USA 












2.3.1 General chemicals 
Acetic acid Carl Roth GmbH & Co. KG, Karlsruhe 
Acetone ROTISOLV Carl Roth GmbH & Co. KG, Karlsruhe 
Adefodur WB developing concentrate Adefo-Chemie GmbH, Dietzenbach 
Adefodur WB fixing concentrate Adefo-Chemie GmbH, Dietzenbach 
Adenosine Triphosphate (ATP) Sigma-Aldrich Co., St. Louis, USA 
Agarose Biozym Scientific GmbH, Hessisch 
Oldendorf 
Albumin Fraction V (BSA Carl Roth GmbH & Co. KG, Karlsruhe 
Ammonium persulfate (APS) Carl Roth GmbH & Co. KG, Karlsruhe 
Ammonium sulfate (NH4)2SO4 Carl Roth GmbH & Co. KG, Karlsruhe 
Antibiotic-Antimycotic Life Technologies, Carlsbad, USA 
Aprotinin Carl Roth GmbH & Co. KG, Karlsruhe 
Bromophenol blue Sigma-Aldrich Co., St. Louis, USA 
Calcium Chloride (CaCl2) Carl Roth GmbH & Co. KG, Karlsruhe 
Chloroform Carl Roth GmbH & Co. KG, Karlsruhe 
Co-precipitant Pink Bioline, Luckenwalde 
Colorless co-precipitant Bioline, Luckenwalde 
Crystal violet Sigma-Aldrich Co., St. Louis, USA 
DePeX mounting media VWR International GmbH 
Diethylpyrocarbonate (DEPC) Carl Roth GmbH & Co. KG, Karlsruhe 
Dimethyl sulfoxide (DMSO) AppliChem GmbH, Darmstadt 
Dithiothreitol (DTT) Carl Roth GmbH & Co. KG, Karlsruhe 
DMEM, no Phenol Red Life Technologies, Carlsbad, USA 
DMEM/F-12, no Phenol Red Life Technologies, Carlsbad, USA 
dNTPs Carl Roth GmbH & Co. KG, Karlsruhe 
Ethanol absolute Th. Geyer GmbH & Co. KG, Renningen 
Ethidium bromide Carl Roth GmbH & Co. KG, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH & Co. KG, Karlsruhe 
Ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA) 
Carl Roth GmbH & Co. KG, Karlsruhe 
EDTA disodium salt (Na2 EDTA) Carl Roth GmbH & Co. KG, Karlsruhe 
Fetal Bovine Serum (FBS) Thermo Scientific HyClone, Logan, USA 
Formaldehyde Sigma-Aldrich Co., St. Louis, USA 
Glycerol Carl Roth GmbH & Co. KG, Karlsruhe 
β-Glycerolphosphate disodium salt 
hydrate 
(BGP) 
Sigma-Aldrich Co., St. Louis, USA 
Glycine Carl Roth GmbH & Co. KG, Karlsruhe 
Glycylglycine AppliChem GmbH, Darmstadt 
Hydrochloric acid (HCl) Carl Roth GmbH & Co. KG, Karlsruhe 
Insulin Sigma-Aldrich Co., St. Louis, USA 
Isopropanol Carl Roth GmbH & Co. KG, Karlsruhe 
Magnesium chloride (MgCl2) Carl Roth GmbH & Co. KG, Karlsruhe 
Magnesium sulfate AppliChem GmbH, Darmstadt 




MEM, no Glutamine, No Phenol Red Life Technologies, Carlsbad, USA 
Methanol Carl Roth GmbH & Co. KG, Karlsruhe 
M-MuLV Reverse Transcriptase Reaction 
Buffer 
New England Biolabs, Frankfurt am Main
N-ethylmaleimide (NEM) Sigma-Aldrich Co., St. Louis, USA 
Nickel Chloride (NiCl2) Sigma-Aldrich Co., St. Louis, USA 
NonidetTM P40 (NP-40) Sigma-Aldrich Co., St. Louis, USA 
Oil Red O Sigma-Aldrich Co., St. Louis, USA 
Opti-MEM GIBCO®, Invitrogen GmbH, Darmstadt 
PBS tablets GIBCO®, Invitrogen GmbH, Darmstadt 
Pefabloc SC Protease Inhibitor Carl Roth GmbH & Co. KG, Karlsruhe 
Penicillin-Streptomycin solution Sigma-Aldrich Co., St. Louis, USA 
Potassium acetate Carl Roth GmbH & Co. KG, Karlsruhe 
Potassium chloride (KCl) AppliChem GmbH, Darmstadt 
Potassium dihydrogen phosphate Carl Roth GmbH & Co. KG, Karlsruhe 
Potassium hydrogen phosphate Carl Roth GmbH & Co. KG, Karlsruhe 
RNase inhibitor New England Biolabs, Frankfurt am Main
RNAiMAX Invitrogen GmbH, Karlsruhe 
Roti®-Phenol Carl Roth GmbH & Co. KG, Karlsruhe 
Rotiphorese® Gel 30 Carl Roth GmbH & Co. KG, Karlsruhe 
Rotipuran® Chloroform Carl Roth GmbH & Co. KG, Karlsruhe 
Rotipuran® Isoamylalcohol Carl Roth GmbH & Co. KG, Karlsruhe 
SepharoseTM CL-4B GE Healthcare, Uppsala, Sweden 
Skim milk powder Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium acetate Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium azide AppliChem GmbH, Darmstadt 
Sodium chloride (NaCl) Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium citrate Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium deoxycholate AppliChem GmbH, Darmstadt 
Sodium Dodecylsulfate (SDS) Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium Fluoride (NaF)     AppliChem GmbH, Darmstadt 
di-Sodium hydrogen phosphate dihydrate Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium hydroxide (NaOH) Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium pyruvate (Na-Pyr) GIBCO®, Invitrogen GmbH, Darmstadt 
SYBR Green I Roche Diagnostics GmbH, Mannheim 
TEMED Carl Roth GmbH & Co. KG, Karlsruhe 
α,α-Trehalose Dihydrate USB Corporation, Cleveland, USA 
Tris Carl Roth GmbH & Co. KG, Karlsruhe 
Triton X-100 AppliChem GmbH, Darmstadt 
TRIzol® Reagent Invitrogen GmbH, Karlsruhe 
Trypsin-EDTA (0.05%) GIBCO®, Invitrogen GmbH, Darmstadt 
Tween-20   AppliChem GmbH, Darmstadt 
Xylene Carl Roth GmbH & Co. KG, Karlsruhe 
 
 




2.3.2 Differentiation chemicals 
Ascorbic acid Sigma-Aldrich Co., St. Louis, USA 
Calcitriol (1α,25-dihydroxy Vitamin D3) Cayman chemicals, Ann Arbor, USA 
Dexamethasone Sigma-Aldrich Co., St. Louis, USA 
ß-Glycerolphosphate (BGP) Sigma-Aldrich Co., St. Louis, USA 
Insulin Sigma-Aldrich Co., St. Louis, USA 
Isobuthylmetylxantine (IBMX) Sigma-Aldrich Co., St. Louis, USA 
Troglitazone Sigma-Aldrich Co., St. Louis, USA 
2.4 Kits and reagents 
Alkaline phosphatase leukocyte kit Sigma-Aldrich Co., St. Louis, USA 
Bioanalyzer DNA High sensitivity kit  
Immobilon Western Chemiluminescent            
HRP Substrate 
Millipore, Billerica, USA 
LipofectamineTM 2000 Invitrogen GmbH, Karlsruhe 
Lipofectamine RNAiMAX Invitrogen GmbH, Karlsruhe 
PageRulerTM Prestained Protein Ladder Fermentas GmbH, St. Leon-Rot 
PureYieldTM Plasmid Midiprep Promega GmbH, Mannheim 
QIAprep® Spin Miniprep Kit Qiagen GmbH, Hilden 
Qubit dsDNA HS assay Invitrogen GmbH, Karlsruhe 
SuperSignal® West Femto Maximum Thermo Fisher Scientific, Waltham, USA 
2.5 Nucleic acids 
2.5.1 siRNA oligonucleotides  
Target gene siRNA target sequence source 








































For transfections, the Dharmacon siRNAs (#1 - #4) were pooled in a 1:1:1:1 ratio. 
2.5.2 Quantitative PCR (qPCR) primers  
All the primers were designed using a primer designing tool from NCBI: 
(www.ncbi.nlm.nih.gov/tools/primer-blast/) in a 5' to 3' direction. The primers were 




2.6.1 Enzymes and substrates 
Coelenterazine Promega Corp. Madison, USA 
Coenzyme A (CoA) Sigma-Aldrich Co., St. Louis, USA 
D-Luciferin Synchem UG & Co. KG, Felsberg / 
Gene Forward Primer (5' to 3') Reverse Primer (5' to 3') Source 
36B4 GATTGGCTACCCAACTGTTG CAGGGGCAGCAGCCACAAA Fritah et al., 2005 
ALPL TGGGCCAAGGACGCTGGGAA AAGGCCTCAGGGGGCATCTCG Karpiuk et al., 2012 
AXIN2 ATTTCCCGAGAACCCACCGCCT  GGCTGTGGCGGCTCTCCAAC  Hossan et al., 2016 
BGLAP CACTCCTCGCCCTATTGGC CTTGGACACAAAGGCTGCAC Hossan et al., 2016 
BMP4 GGAGCTTCCACCACGAAGAA GGAAGCCCCTTTCCCAATCA Hossan et al., 2016 
DKK1 CGGGCGGGAATAAGTACCAG TTTGCAGTAATTCCCGGGGC Hossan et al., 2016 
HNRNPK ATCCGCCCCTGAACGCCCAT ACATACCGCTCGGGGCCACT Karpiuk et al., 2012 
LEF1 GACGAGATGATCCCCTTCAA CGGGATGATTTCAGACTCGT Hossan et al., 2016 
LRP4 ATAAGAAAGAGGGAGGGCCTGA TGAGGTCATCCCACTCAGCA Hossan et al., 2016 
PDK4 TTCACTCCGCGGCACCCTCA TCGGAGCAGAGCCTGGTTCCG Karpiuk et al., 2012 
PPARG ACCTCCGGGCCCTGGCAAAA TGCTCTGCTCCTGCAGGGGG Karpiuk et al., 2012 
RASD1 CAAGACGGCCATCGTGTCGCG GCTGCACCTCCTCGAAGGAGTCG Karpiuk et al., 2012 
RUNX2 TCGGAGAGGTACCAGATGGG CATTCCGGAGCTCAGCAGAA Hossan et al., 2016 
SP7 TTCTGCGGCAAGAGGTTCACTC GTGTTTGCTCAGGTGGTCGCTT Hossan et al., 2016 
SSRP1 AAAGGTTCCATGAATGATGGTC GCCTGGATGTTGTCCACTTT Hossan et al., 2016 
TCF7L2 CCTGGCACCGTAGGACAAAT GGAACCTGGACATGGAAGCA Hossan et al., 2016 
VDR TGGAGACTTTGACCGGAACG GGGCAGGTGAATAGTGCCTT Hossan et al., 2016 
WISP2 CATGCAGAACACCAATATTAAC  TAGGCAGTGAGTTAGAGGAAAG Johnsen et al., 2009 
WNT11 GCCAAGTTTTCCGATGCTCC GACACCCCATGGCACTTACA Hossan et al., 2016 
WNT2 GGATGCCAGAGCCCTGATGAATC GCCAGCCAGCATGTCCTGAGAGT Hossan et al., 2016 





Proteinase K Invitrogen GmbH, Karlsruhe 
Reverse Transcriptase (M-MuLV) New England Biolabs, Frankfurt am Main  
RNase A Qiagen GmbH, Hilden 
Taq DNA Polymerase Prime Tech, Mink, Belarus 
2.6.2 Antibodies 
2.6.2.1 Primary antibodies 
Following antibodies and dilutions were used for Western Blot (WB) and 
Immunofluorescence (IF) staining. 
Target Protein Clone Cat No. WB IF Source 
β-actin I-19 sc1616 1:5000 - Santa Cruz 
Active-β-catenin D13A1 8814S - 1:300 Cell Signaling 
HSC70 B-6 sc7298 1:25000 - Santa Cruz 
SSRP1 3E4 609802 1:1000 1:300 Biolegend 
2.6.2.2 Secondary antibodies for WB 
Name Dilution Catalog No. Source 
Goat anti-mouse IgG-
HRP 
1:5000 sc-2005 Santa Cruz 
Goat anti-rabbit IgG-HRP 1:5000 sc-2004 Santa Cruz 
 
 
2.6.2.3 Secondary antibodies for IF 
Name Dilution Reference No. Source 
Alexa Fluor®594 anti 
mouse-IgG 
1:500 A11005 Life Technologies, 
Carlsbad, USA 
Alexa Fluor®488 anti 
mouse-IgG 
1:500 A11008 Life Technologies, 
Carlsbad, USA 
2.7 Plasmids 
Following plasmids were used in this study 
 









pTAluc 900 ng Wnt reporter (8X TBE) Veeman et al., 2003 
super-FOP-
FLASH 
pTAluc 900 ng Wnt reporter negative 
Control (8X mut TBE) 
Veeman et al., 2003 




pCl-neo 500 ng Mutated beta catenin Kendziorra et al., 2011 
pCl-neo pCl-neo 500 ng Empty vector Promega(cat #E1841) 
2.8 Cells 
2.8.1 Human cell lines 
Human fetal osteoblasts (hFOB1.17) Prof. T. Spelsberg, Mayo Clinic, 
USA 
Human mesencymal stem cells 
(hMSC) 
Prof. M. Kassem, Odense University 
Hospital, Denmark 
U20S Prof. T. Spelsberg, Mayo Clinic, USA 
2.8.2 Wnt3a producing cells 
L-Cells Prof. Tobias Pukrop, UMG, Göttingen 
L-Cells Expressing Wnt3a Prof. Tobias Pukrop, UMG, Göttingen 
 
 
2.9 Buffers and solutions  
RIPA buffer  
PBS 1X   
NP-40       1%  
Sodium deoxycholate    0.5%  
SDS 0.1% 
TBS-T 10X (pH 7.6)  
Tris 0.1 M 
NaCl 1.5 M 
Tween-20 0.5% 
Western salts 10X 
Tris  0.25 M 
Glycine  0.86 M 
SDS 0.7 M 




PBS-T 10X (pH 7.4) 
NaCl 0.73 M 
KCl 0.027 M 
NaH2PO4 * 7H2O 14.3 mM 
KH2PO4 14.7 mM 
Tween-20 1% 
PBS for cell culture 
1 PBS tablet per 500 ml distilled H2O  
PBS-T  
PBS including 0.1% (w/v) Tween-20   
PCR-Mix 10X 
Tris-HCl (pH 8.8) 750 mM 
(NH4)2SO4 200 mM 
Tween-20 0.1% 
RT-PCR master mix 
PCR-Mix 10X 1X 
MgCl2 3 mM 
SYBR Green 1:80000 
dNTPs 0.2 mM 
Taq-polymerase 20U/ml 
Triton X-100 0.25% 
Trehalose 300 mM 
Blocking solution 
Skim Milk 5% 
TBST 1X 
Cell culture freezing medium 









Protease, phosphatase and deubiquitinase inhibitors 
Pefabloc 1 mM 
Aprotinin/Leupeptin 1 ng/µl 
BGP 10 mM 
NEM 1 mM 
IAA 10 mM 
NICl2 1 mM 
DMEM/F12 cell culture medium 
Phenol red-free high-glucose DMEM/F12 with 10% FBS, 1× Penicillin/Streptomycin 
DMEM cell culture medium 
Phenol red-free, high-glucose DMEM, 10% BGS, 1× Penicillin/Streptomycin 
MEM cell culture “normal” medium: phenol red-free, high-glucose MEM, 10% 
BGS, 1× Antibiotic-Antimycotic solution 
MEM cell culture “adipocyte” medium: phenol red-free, high-glucose MEM, 15% 
FBS, 1× Antibiotic-Antimycotic solution, 10 nM dexamethasone, 0.45 mM isobutyl-
methyl-xanthine, 2 µM insulin, 10 µM Troglitazone. 
MEM cell culture “osteoblast” medium: phenol red-free, high-glucose MEM, 10% 
FBS, 1× Antibiotic-Antimycotic solution, 10 nM dexamethasone, 10 mM ß-glycerol 
phosphate (BGP), 0.2 mM ascorbic acid, 10 nM calcitriol. 
Ascorbic acid stock solution (1000x) 
0.2 M ascorbic acid in sterile water 
Calcitriol stock solution (1000x) 
10 µM calcitriol in 100% DMSO 
Dexamethasone stock solution (1000x) 
100 µM dexamethasone in 100% EtOH 
β-glycerol phosphate (BGP) stock solution (100x) 
1 M BGP in sterile water 




IBMX stock solution (100x) 
0.45 M isobutyl-methyl-xanthine in 100% EtOH 
Troglitazone stock solution (1000x) 
10 mM Troglitazone in 100% DMSO 
6x Laemmli buffer 
 




Bromophenol Blue 0.02% 
 
SDS separating gel (X%) 
 
Acrylamide X%  





SDS stacking gel (5%) 
Acrylamide 5% 




TAE buffer (50x) 
Tris 2 M 
Acetic acid 1 M 
EDTA 0.1 M 
Transfer buffer 
10X Western Salts 10% 
Methanol 15%  
Firefly buffer (pH 8.0) 
Glycylglycine 25 mM 
K2HPO4 15 mM 
EGTA 4 mM 





Renilla buffer (pH5.1): 
NaCl 1.1 M 
Na2EDTA 2.2 mM 
K2HPO4 0.22 M 
Firefly working reaction buffer 
Per 10 ml firefly buffer following reagents were added 
MgSO4 15mM 
ATP pH 7.0 4 mM  
DTT 1.25 mM 
CoA 0.1 mM  
Luciferin 80 µM 
 
Renilla working reaction buffer 
Per 10 ml renilla buffer following reagents were added 
BSA 0.5 mg/ml 
NaN3 1.5 mM 



















3.1 Cell culture 
3.1.1 Culture conditions for hMSC, hFOB and U2OS                       
hMSCs were cultured in low glucose Minimum Essential Media (MEM) without 
glutamine and Phenol Red supplemented with 10% FBS, 1× Antibiotic-Antimycotic at 
37°C with 5% CO2. To induce adipocytic differentiation cells were cultured in 
presence of 15% FBS, 10 nM dexamethasone, 0.45 mM isobutyl-methyl-xanthine, 2 
µM insulin, 10 µM Troglitazone and 1× Antibiotic-Antimycotic solution. For osteoblast 
differentiation the cells were cultured in the media contained 10% BGS, 10 nM 
dexamethasone, 10 mM ß-glycerol phosphate (BGP), 0.2 mM ascorbic acid, 10 nM 
calcitriol and 1× Antibiotic-Antimycotic solution. 
hFOB 1.17 cells were cultured in high glucose, phenol red free DMEM/F-12 
supplemented with 10% Fetal Bovine Serum (FBS) and 1× Antibiotic-Antimycotic at 
the permissive temperature 34°C with 5% CO2 supply. For induction of the 
differentiation to osteoblasts cells were cultured in the same medium with the 
osteoblast differentiation factors at 39°C (restrictive temperature) with 5% CO2. 
U2-OS cells were cultured in high glucose, phenol red free DMEM 
supplemented with 10% FBS and 1× Penicillin/Streptomycin at 37°C with 5% CO2. 
3.1.2 Cell culture for obtaining Wnt3a containing conditioned media 
L-cells and L-cells expressing Wnt3a protein were used to obtain the 
conditioned medium. For maintaining the cells in the culture phenol red-free, high-
glucose DMEM supplemented with 10% FBS, 1% sodium pyruvate and 1X 
Penicillin/Streptomycin media was used at 37°C with 5% CO2.  
For obtaining the conditioned medium, cells were split into 1:10 in 15 mL 
culture medium using 20 cm culture plate. The cells were grown for 4 days to attain 
an approximate confluency. Then the medium were taken off and filtered using 0.20 
µm sterile filters. These were considered as the first batch of the conditioned medium. 
The cells were cultured for another 3 days and then the second batch of the 




conditioned medium was collected. The first and second batch were then mixed as 
1:1 ratio from the respective plates. These medium contained Wnt3a protein.  
3.1.3 siRNA mediated reverse transfection 
siRNA mediated reverse transfection was performed using Lipofectamine TM 
RNAiMAX according to the manufacturer’s instructions. For transfection in 6-well 
plate 30 pmol corresponding siRNAs were used in 500 µl Opti-MEM along with 5 µl 
of LipofectamineTM RNAiMAX. Then the mix was incubated in room temperature for 
20 minutes. In the meantime, cells were trypsinized and counted using Neubauer 
counting chamber. Then, approximately 250,000 cells were used for the transfection 
in 6-well plate for hMSC and U2-OS, whereas 300,000 cells were used in case of 
hFOB. During transfection the media without antibiotic was used. After 24 hours of 
transfection the media with antibiotics was used along with the respective 
differentiation media. For trnasfcetion into 12 well as well as 24 well plate, the 
transfection reagents were scaled and calculated accordingly. 
3.1.4 Plasmid DNA transfection 
For transfections into 24-well format approximately 1.9 µg of total plasmids 
DNA were diluted in 50 µl of OptiMEM media. In a separate tube, 3 µl of 
Lipofectamine TM 2000 were diluted in a total volume of 50 µl of OptiMEM. Both 
solutions were incubated at room temperature (RT) for 15 min followed by mixing 
and additional incubation for 20 min at RT. After that a total mix of 100 µl was added 
to the cells grown in media without antibiotics. 5 h after transfection the cells were 
washed with PBS and antibiotic containing media was added. 
3.1.5 Cell proliferation assay 
Cell proliferation assay was performed by crystal violet staining. Cells were 
washed twice with 1X PBS followed by incubation in crystal violet staining solution 
containing 0.1% (w/v) crystal violet, 10% (v/v) formaldehyde for 10 min at RT. Then 
the cells were washed gently with distilled water. Finally cells were kept for drying 
and the whole plate was scanned using Epson 1680 in 300 dpi resolution at 48-bit 
RGB color. 




3.2 Molecular Biology 
3.2.1 RNA isolation   
RNA isolation was performed using QIAzol® reagent according to the 
manufacturer’s instructions. Cells were washed twice with PBS, lysed by adding 500 
µl of QIAzol® reagent to each well (6-well format) and scraped into 1.5 ml tubes. 100 
µl of chloroform was added to the samples followed by vortexing for 20 sec and then 
centrifuged at 10,000g for 20 min (4°C). The aqueous phase was collected into a 
fresh 1.5 ml tube and chloroform extraction was performed again followed by 2 h or 
overnight isopropanol precipitation at -20°C. After that, samples were centrifuged at 
maximal speed of 12,000g for 30 min (4°C), pellets were washed twice with 70% 
ethanol, dried on vacuum concentrator and re-dissolved in 40 μl of DEPC water. 
RNA concentration was measured using a NanoDrop. 
3.2.2 cDNA synthesis 
For DNA synthesis 1 µg of total RNA was mixed with 2 µl of 15 µM random 
primers and 4µl of 2.5 mM dNTP mix and incubated 5 min at 70°C. After that 4 µl of 
reverse transcription master mix containing 2 µl 10x reaction Buffer, 10 units of 
RNAse Inhibitor, 25 units of Reverse Transcriptase and 1.625 µl of DEPC water 
were added to each sample. cDNA synthesis was performed at 42°C for 1 h followed 
by enzyme inactivation for 5 min at 95°C. Finally, samples were brought to 50 µl 
volume by adding DEPC water. 
3.2.3 Quantitative real-time PCR   
For quantitative real-time PCR 1 μl of cDNA sample was used in a final 
reaction volume of 25 μl. A PCR reaction contained 75 mM Tris-HCl (pH 8.8), 20 mM 
(NH4)2SO4, 0.01% Tween-20, 3 mM MgCl, 200 µM dNTPs, 0.5 U/reaction Taq DNA 
Polymerase, 0.25% Triton X-100, 1:80,000 SYBR Green I, 300 mM Trehalose and 








The two-step PCR protocol used was setup as follows: 
95° C – 2 min 
95° C- 15 Sec 
60° C- 1 min         X 40 
The PCR reaction was followed by a melting curve analysis from 60°C to 95°C with 
read every 0.5°C.  
cDNA samples were quantified using a standard curve made from all cDNA 
samples. Quantified samples were normalized to 36B4 (RPLPO) or HNRNPK as an 
internal reference gene. The expression levels were determined relative to the 
vehicle treated control sample and expressed as “relative mRNA expression”.  
ANOVA-single factor test was used for analyzing statistical significance.  
3.2.4 RNA-sequencing and analysis 
RNA-sequencing was performed at the sequencing facility by Heinrich Pette 
Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany. 
RNA integrity was checked using Bioanalyzer 2100 (AgilentTechnologies, 
Palo Alto, CA, http://www.agilent.com), and 1 µg of total RNA was prepared for 
sequencing using the NEBNext Ultra RNA Preparation kit for Illumina (New England 
Biolabs) according to the manufacturer’s instructions. 300 bp size range was 
confirmed using Bioanalyzer. Then, amplification and cluster generation of these 
samples were done using cBot with 50 cycles and 50 bp single end sequencing was 
performed on an Illumina HiSeq 2500. Fastq files were used for mapping to the 
human reference transcriptome (UCSC HG19) using Bowtie 2 (version 2.1.0). Read 
counts for each sample and gene were counted using a custom Ruby script. 
Differential expression was analyzed by DESeq (version 1.14.0 (Anders and Huber, 
2010). R-based heatmap.2 in gplots package was used for generating heatmaps. 
Threshold levels for fold changes in upregulated and downregulated genes were 
log2FC ≥ 0.585 and logFC ≤ -0.515. Adjusted p value (pAdj) was calculated 
according to Benjamini Hochberg. pAdj ≤ 0.05 was used as the significance level. 
The online gene ontology (GO) resource DAVID (Huang et al., 2009, 2009) was 
used to analyze the SSRP1-dependent genes with the cutoff values as used for 




generating heatmap. A list of Wnt signaling genes was made from KEGG (Kanehisa 
and Goto, 2000; Kanehisa et al., 2016) and NetPath (Kandasamy et al., 2010) 
database. Each of the genes from the gene list was checked for their log2fold 
expression changes in RNA-seq data with a significance level pAdj ≤ 0.05. Then a 
heatmap was generated by heatmap 2. 
The Wnt-signaling pathway map was drawn by the CellDesigner software 
(Funahashi et al., 2003, 2008). Numerical values of log-fold changes were used from 
RNA-seq data. The threshold levels were from +1 [log2(2) = 1] to -1 [log2(0.5) = -1]. 
The expression values below -1 or above +1 were assigned for the most intense 
color codes. The nodes were colored in Cytoscape (Shannon et al., 2003) using 
BiNoM plugin. 
3.2.5 Dual luciferase assay 
For dual luciferase reporter assay, the hFOB or U2-OS cells were transfected 
with control and SSRP1 siRNAs  as described in section 3.1.3. 24 h after 
transfection the media was changed with antibiotic. After 48 h the cells were 
cotransfected with Super-TOP- or Super-FOP-FLASH plasmids (Veeman et al., 2003) 
(900 ng per well) containing eight copies of a wild-type or mutated TCF/Lef binding 
site. An internal control plasmid expressing Renilla luciferase (100 ng) (pRL-CMV; 
Promega) was also cotransfected at the same time. Where indicated, cells were 
additionally transfected with a control vector (pCI-neo; Promega) or a vector 
expressing a constitutively active form of β-catenin containing an S33Y mutation 
(Kendziorra et al., 2011). Then after 4 h of plasmids DNA transfection the cells were 
washed once with 1XPBS followed by the media change with antibiotic. Additionally, 
Wnt3a containing conditioned media was diluted with normal cell culture media as 
3:1 and then was used in the indicated wells to induce Wnt-signaling pathway. The 
dual luciferase reporter assay was performed as described by Dyer et al., (Dyer et al., 
2000). However, the measurement setup was as follows: 
 Dispense > Injector, Volume (100 µl), Speed (Middle), by plate/by well. 
 Delay > 2 s 
 Measurement > 10 s 
 




3.3 Protein biochemistry  
3.3.1 SDS-PAGE   
SDS-PAGE was used for separating proteins using denaturing agent SDS 
(sodium dodecylsulfate) on a polyacrylamide gel upon electrophoresis (Laemmli, 
1970). Proetin samples were prepared by cell lysis in RIPA buffer containing the 
protease inhibitors 1 mM Pefabloc, 1 ng/μl  Aprotinin/Leupeptin, 10 mM BGP and 1 
mM NEM. Genomic DNA was sheared by sonication where samples were sonicated 
for 10 sec at 10% power using a tip sonicator. Before loading, protein samples were 
boiled in Laemmli buffer for 10 min at 95°C and then subjected to SDS-PAGE. The 
composition of stacking and resolving gel is described in section 2.8. Polyacrylamide 
gels were run in SDS running buffer at 20 mA/gel.   
3.3.2 Western blot analysis   
After electrophoresis, proteins of interest were separated and detected 
according to their molecular weight using specific antibodies (Towbin et al., 1979). 
Separated proteins were transferred to PVDF nitrocellulose membranes at 100 V 
using transfer buffer for 90 min, depending on the size of the protein. The 
membranes were incubated in 1X TBST 5% (w/v) milk for 1 h to block non-specific 
antibody binding. Afterwards the membranes were incubated for 1 h at room 
temperature or overnight at 4°C in the same blocking buffer containing the respective 
primary antibodies, diluted as described in the antibody table (2.6.2.1). After that the 
membranes were washed twice with 1X TBS-T followed by the incubation for 1 h 
with the corresponding horseradish peroxidase-conjugated anti-mouse IgG or anti-
rabbit IgG secondary antibodies in appropriate dilutions. Further the membranes 
were washed twice by 1X TBS-T and the HRP signals were detected using 
enhanced chemoluminescence and exposed to X-ray films.  
3.3.3 Immunofluorescence  
For immunofluorescence staining, the cells grown on chamber slides,  
washed with 1X PBS and fixed with 4% paraformaldehyde for 15 min at RT. Cells 
were washed twice with 1X PBS and  permeabilized using 0.1% Triton X-100 for 10 
min. After washing twice with 1X PBS, cells were blocked with 10% FBS for 10 min 




followed by overnight incubation with primary antibody dilution in 3% BSA. Next day, 
unbound antibodies were washed away by washing twice with 1X PBS and 
incubated with Alexa-488 or Alexa-594 conjugated secondary antibodies. Cells were 
washed twice with 1XPBS and stained for DAPI and mounted with coverslips using 
mounting medium. Images were taken using LSM 510 META confocal microscope 
and analyzed using the LSM Image Browser. 
3.4 Staining 
3.4.1 Alkaline phosphatase staining   
Osteoblast differentiation efficiency was determined by staining for alkaline 
phosphatase activity. Staining was performed with alkaline phosphatase kit for 
leukocytes according to manufacturer’s instructions. All steps were performed at RT. 
First, cells were washed with PBS and fixed for 30 sec with Citrate fixing solution 
containing (for 98 ml): 66 ml acetone, 25 ml Citrate solution and 8 ml 37% 
formaldehyde. After fixation, cells were washed three times with distilled water and 
incubated in dark for 15 min with diazonium salt followed by rinsing with distilled 
water and drying. Diazonium salt preparation: 1 ml of FRV-Alkaline solution was 
mixed with 1 ml of sodium nitrate solution and incubated for 2 min. Then 45 ml of 
distilled water and 1 ml of Naphtol AS-BI Alkaline solution were added to the mix. 
Diazonium salt was prepared freshly before each staining. Microscopic images were 
taken by a Zeiss Axiovert 40 using 10X magnification.  
3.4.2 Oil Red O staining   
Presence of lipid droplets indicative for adipocyte differentiation efficiency 
were detected by Oil Red O staining. All steps were performed at RT. Oil Red O 
working solution was prepared by mixing 3 parts of Oil Red O stock solution (300 
mg/ml of Oil Red O powder in 99% isopropanol) with 2 parts of distilled water and 
incubated for 10 min followed by filtration. Cells were washed with PBS, fixed with 10% 
formaldehyde for 30 min and incubated with 60% isopropanol for 5 min. Then, cells 
were stained with Oil Red O working solution for 5 min in dark followed by rinsing 
with distilled water and drying. Pictures of the stained plates were taken under light 
microscope using 20X magnification.         





Stem cells and stem cell like cells which can differentiate into multiple cell 
lineages undergo constant and dynamic changes of the native chromatin structure 
where different chromatin remodeling factors including histone chaperones could be 
an essential part. Though the knowledge on functions of histone chaperone during 
cellular differentiation is limited, but it has been started to be revealed. For instance, 
the histone chaperone ASF1A was shown to be required for maintenance of 
pluripotency and cellular reprogramming (Gonzalez-Muñoz et al., 2014) for human 
adult dermal fibroblasts (hADFs). Another report showed the histone chaperone 
SUPT6H in regulating muscle gene expression and cellular differentiation through 
demethylation of H3K27me3 marks (Wang et al., 2013). The fundamental functional 
aspects of histone chaperones in dynamic remodeling of chromatin suggest their 
essential role in cellular differentiation. It is likely they could also promote lineage 
specificity from a specific stem cell where differentiation to one cell type could be 
conducted through the inhibition of differentiation to the other types. Indeed, recent 
evidences suggest the lineage specific function of some of the histone chaperones. 
HIRA and ASF1 were reported to be diminished more than 50% during osteoblast 
differentiation from C2C12 cells, while they were maintained through the entire 
period of myotube differentiation (Song et al., 2012b). Interestingly, suppression of 
the CAF-1 promoted the enhanced conversion of B cells into macrophages and 
fibroblasts into neurons  (Cheloufi et al., 2015). CHAF1A is a component of CAF-1, 
which was reported to block the differentiation of embryonal neural crest 
differentiation which ultimately results to the pathogenesis of high-risk 
neuroblastoma (Barbieri et al., 2014). Overall it is apparent that modulating 
chromatin state through the histone chaperones could be an important aspect of 
cellular differentiation or lineage specificity. In this study we investigated the lineage 
specific role of the histone chaperone component SSRP1.  
4.1 SSRP1 depletion enhances adipocytes differentiation 
In order to understand the effects of SSRP1 on adipocyte differentiation 
potency of hMSC we performed siRNA mediated knockdown followed by a 7 days of 
differentiation toward adipocytes by the differentiation mix containing 
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lipid droplets than the solvent used to dissolve the dye. Thus when there are lipid 
droplets present in the cells dye dissolve there and turn into red color. We found an 
increased number of red droplets indicative for the presence of fat (Figure 7B).  
Further the gene expression study using commonly used adipocyte differentiation 
marker genes such as PPARG, PDK4, RASD1 also showed a significant increase in 
their expression following SSRP1 knockdown and adipocyte differentiation for 7 days 
(Figure 7D). Notably, the nuclear receptor peroxisome proliferator activated receptor 
gamma (PPARG) is one of the key regulators of adipocyte differentiation (Chawla et 
al., 1994) both in vitro and in vivo (Barak et al., 1999; Rosen et al., 1999). Moreover 
increased PDK4 expression was reported to be correlated with higher PPARG 
expression (Holness et al., 2012). RASD1 is another important protein to promote 
adipogenesis confirmed in both in vivo and in vitro (Cha et al., 2013; Karpiuk et al., 
2012; Kemppainen and Behrend, 1998) 
 
4.2 SSRP1 depletion decreases osteoblast differentiation 
Next, we investigated the effects of SSRP1 on osteoblast differentiation. For 
this purpose, we used hMSC, performed siRNA mediated knockdown and induced 
osteoblast differentiation for 7 days with the differentiation mix containing calcitriol 
(vitamin D, nuclear receptor ligand) dexamethasone (glucocorticoid receptor agonist), 
ascorbate (vitamin C, required for collagen synthesis) and β-glycerophosphate 
(required for mineralization of collagen matrix). The efficient knockdown was 
demonstrated by western blot using antibody against SSRP1 (Figure 8A). Alkaline 
phosphatase staining was used as readout for differentiation efficiency (Figure 8B). 
Alkaline phosphatase is a well-known marker for osteoblast differentiation and is 
required for the mineralization and calcification. Thus the osteoblasts expressing 
alkaline phosphatase can convert certain chemicals into violet color indicative for the 
differentiation efficiency. 
The finding was further confirmed by the gene expression analysis using qRT-
PCR. Some of the key osteoblast differentiation marker genes such as ALPL, 
BGLAP, RUNX2 and SP7 were examined. All of them showed a significant 
decreased expression following SSRP1 knockdown (Figure 8C). Together these 


























































e is labeled 
inst SSRP1
ation was ve
s. (C) Real 
tion specific
an internal r










es of the 
reases oste
ed by an in








































































































 (n = 3). 
P1 in 

































































































































nd MYH1.  T
tive to the U






































l. ***p ≤ 0.0
n used w
lso shares



























that are more advanced in their osteogenic differentiation compared to hMSCs, 
making hFOB as an interesting biological tool to study bone development as well 
different bone-related diseases (Krattinger et al., 2011; Panaroni et al., 2014). Thus, 
we investigated whether SSRP1 also influences osteoblast-specific gene expression 
in hFOB cells. At first, we examined alkaline phosphatase activity of hFOB cells after 
7 days of differentiation following siRNA-mediated knockdown of SSRP1. Consistent 
with the previous results in hMSC, hFOB cells also showed a drastic decrease in 
alkaline phosphatase activity (Figure 10B).  
We also examined the mRNA expression level of different osteoblast specific 
genes including ALPL, RUNX2 and VDR following siRNA transfection and 
differentiation to osteoblasts (Figure 10C). We found a marked decrease in the 
expression level of ALPL, RUNX2 and VDR following SSRP1 depletion and 
osteoblast differentiation.  
4.5 SSRP1 knockdown shows dramatic and specific changes in gene 
expression during osteoblast differentiation 
Next, we wanted to determine the extent to which SSRP1 directs transcriptional 
reprograming during osteoblast differentiation. We performed transcriptome-wide 
RNA sequencing in hFOB cells following SSRP1 depletion. At first we checked the 
variability between the samples of different experimental conditions. Principle 
component analysis (PCA) was used to measure the variability within and between 
the samples of each condition. 2 replicates of each of the 3 biological conditions 
termed as undifferentiated control (UND_ConSi), osteoblast differentiated control 
(OST_ConSi) and osteoblast differentiated SSRP1 knockdown (OST_SSRP1) were 
used for high throughput sequencing. Figure 11 A shows the distance between the 
samples of each condition and Figure 11B shows the heatmap which were 
generated from the log2-transformed data. The results showed minimal or no 
variance between the samples of respective conditions.  
Then we investigated the impact of SSRP1 depletion on osteoblast 
differentiation. We produced a heatmap to show the pattern of differentially 
expressed genes during osteoblast differentiation. The selection criteria of the genes 
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biological processes include glycoprotein and glycosylation, extracellular matrix, cell-
cell adhesion, ossification, osteoblast differentiation and osteogenesis, bone and 
skeletal system development, Wnt-signaling pathways etc. Notably all of these 
processes and pathways are crucial for osteoblast differentiation to bone 
development at different stages. For example, glycoprotein and glycosylation of 
membrane proteins playing role in signal transduction. Proteins of the extracellular 
matrix are critical for cell to cell contact as well as for maturity of the osteoblasts.  
4.7 Wnt signaling pathway as a target of SSRP1 
4.7.1 SSRP1 mediates transcriptional regulation of Wnt signaling pathway 
genes 
One of the striking outcomes of GO analysis was the enrichment of genes 
involved in Wnt signaling (Table 1), a central pathway controlling osteoblast 
differentiation (Baron and Kneissel, 2013) whose activity was perturbed following 
SSRP1 depletion. Then we generated a heatmap to show the changes in gene 
expression pattern which displayed the Wnt signaling pathway genes were 
expressed during osteoblast differentiation whose activity was inhibited after SSRP1 
knockdown (Figure 13). These results clearly show an involvement of SSRP1 with 
Wnt signaling pathway where SSRP1 could regulate the pathway activity. Therefore 
we verified the changes in gene expression of several key Wnt signaling genes as 
well as Wnt target genes including AXIN2, BMP4, DKK1, LEF1, LRP4, TCF7L2, 
WNT2, WNT11 and WISP2. A number of these genes showed a significant decrease 
in expression following SSRP1 depletion (Figure 14). In addition, the effects of 
SSRP1 depletion on the Wnt-signaling pathway during osteoblast differentiation was 
further verified using a custom-made Wnt-signaling pathway map (Figure 15). 
All together we show an essential need of SSRP1 for the functional activity of 
the Wnt signaling pathway which could be disrupted by the depletion of SSRP1. 
Notably Wnt signaling plays a pivotal role during osteoblast differentiation and bone 
development. Thus these results indicate that previously observed effects of SSRP1 
on osteoblast differentiation could be due to SSRP1-mediated regulation through 
Wnt-signaling. 
 








































Table 1: SSRP1 dependent biological processes revealed by GO analysis. The table lists GO 
terms in biological processes deregulated by SSRP1 knockdown. Important biological processes 
required for osteoblast differentiation are marked as blue. Log2 FC ≤ -0.515 and pAdj ≤ 0.05 were the 
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Several genes necessary for late or terminal osteoblast differentiation are 
overexpressed in osteosarcoma (Haydon et al., 2007; Sadikovic et al., 2010; Wagner 
et al., 2011). Considering these points we used U2OS osteosarcoma cells in addition 
to hFOB for further verification of the SSRP1 involvement in the Wnt signaling 
pathway.  
The super-TOP FLASH reporter construct contains 8 optimal copies of 
TCF/LEF sites upstream of a thymidine kinase minimal promoter that in response to 
activation of Wnt pathway β-catenin bind to TCF/LEF transcription factor and induces 
transcription of luciferase reporter gene. In contrast super-FOP FLASH contains 
mutated copies of the TCF/LEF binding sites. Thus β-catenin does not have the 
binding partners which result in inhibition of luciferase reporter gene used as a 
negative control (Figure 16A, 16B). We performed siRNA-mediated knockdown of 
SSRP1 followed by Wnt3a treatment for induction of Wnt-signaling. We observed 
consistent results from both the cell lines where SSRP1 depletion led to a significant 
decrease in Wnt3a-induced reporter activity following SSRP1 knockdown (Figure 
16C, 16D). These results further confirm the critical necessity of SSRP1 for the 
transcriptional activity of Wnt signaling pathway during osteoblast differentiation. 
4.7.3 SSRP1 is required for nuclear translocation of active β-catenin 
Given the fact that SSRP1 was required for Wnt pathway activity and also 
exerted control on different components of the pathway including ligands, receptors, 
mediators, regulators and targets as well, we next examined whether SSRP1 
depletion affected nuclear translocation of β-catenin. We therefore performed 
immunofluorescence analyses for SSRP1 and active (non-phosphorylated) β-catenin 
in U2OS cells following SSRP1 knockdown. Here we also induced Wnt signaling 
pathway using Wnt3a containing conditioned media. 
We observed a significant colocalization of SSRP1 and β-catenin in the 
nucleus following Wnt3a treatment which was disrupted after SSRP1 depletion. 
Importantly, SSRP1 depletion resulted in a reduction of active‐β‐catenin in the 
nucleus to levels found in uninduced control cells (Figure 17A). Protein analyses by 
western blot also showed decreased levels of active β-catenin following SSRP1 
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U2OS cells were transfected with control or single/smart pool SSRP1 siRNAs. After 36 h, cells were 
transfected with super‐TOP	 FLASH constructs together with an internal Renilla luciferase expression 
vector. Cells were cultured for an additional 24 h under stimulation with Wnt3a or control conditioned 
media. Wnt signaling pathway activity is shown as relative firefly luciferase activity normalized to 
Renilla luciferase activity and shown relative to the control condition (cells treated with conditioned 
medium from non‐Wnt3a‐expressing L‐cells). Here, SSRP1 # smp means SSRP1 smart pool siRNA, 










Cellular differentiation is a tightly regulated process involving multiple 
orchestrated control mechanisms. These mechanisms exert critical role in the 
emergence of different cell types from a particular stem cell. Nevertheless one of the 
important factors which control the regulation of cell differentiation is the highly 
compact and condensed structure of chromatin, which provides a fundamental 
barrier for all the DNA associated processes essential for differentiation. Therefore 
alteration of chromatin architecture by various chromatin modifying factors is 
essential for cell differentiation.  
The histone chaperone FACT was reported to be highly expressed in the 
undifferentiated, less differentiated or stem cell like cells compared to the adult 
mammalian cells (Garcia et al., 2011, 2013). However, the specific role of the FACT 
complex in cellular differentiation or lineage specific cell fate decision is still unknown. 
Our studies suggest that FACT component SSRP1 plays a role in regulating lineage 
specific cellular differentiation towards adipocyte and osteoblast through affecting the 
transcription components of these two processes. Moreover we demonstrate a novel 
link between SSRP1 and Wnt signaling which is essential for regulating osteoblast 
differentiation. 
5.1 SSRP1 elicits lineage specificity between adipocyte and osteoblast 
5.1.1 SSRP1 regulates adipocyte differentiation 
hMSCs are multipotent stem cells which can differentiate into a number of cell 
lineages including adipocytes, osteoblast, chondrocyte, myoblast and neurons. 
Nevertheless the exact mechanisms how the lineage specificity is determined by the 
cells still unknown. The nuclear receptor Peroxisome Proliferator-Activated Receptor 
Gamma (PPARγ or PPARG) is one of the master regulators for adipocyte 
differentiation and adipogenesis which becomes activated by a series of 
transcriptional events. Upon stimulation by 3-isobutyl-1-methylxanthine (IBMX) and 
dexamethasone induction of CCAAT/enhancer binding protein-β (CEBPB) and -δ 
(CEBPD) happens. Mitogen Activated Protein Kinase (MAPK) and Glycogen 
Synthase Kinase-3β (GSK-3β) play an essential role in the hyperphosphorylation 




and activation of CEBPB, which increases the DNA binding affinity of both CEBPs, 
then leads to the expression of PPARG as well as CEBPA, which subsequently 
induces the expression of other genes necessary for adipocyte differentiation. 
Increased PDK4 expression was found to be correlated with the enhanced 
expression of PPARG (Holness et al., 2012). In another study, overexpression of  
RASD1 enhances expression of PPARG, CEBPA as well as other adipocyte 
differentiation marker genes (Cha et al., 2013). It is likely that the changes in the 
gene expression pattern during adipocyte differentiation require dynamic remodeling 
of chromatin. ATP-dependent chromatin remodeling enzymes SWI/SNF were 
reported to be required for the activation of PPARG preceded by preinitiation 
complex formation  and recruitment of SWI/SNF on PPARG promoter along with 
TFIIH and other general transcription factors (Salma et al., 2004). Jun Dimerization 
Protein 2 (JDP2) was reported to have the histone chaperone activity and 
suppresses adipocyte differentiation through inhibiting the acetylation of H3 in the 
promoter of CEBPD (Nakade et al., 2007). In this study, we show that the depletion 
of the histone chaperone protein SSRP1 promoted adipocyte differentiation. The 
expression of key adipocyte differentiation marker gene PPARG is significantly 
increased following SSRP1 knockdown and adipocyte differentiation. We also 
observed that the expression of other adipocyte differentiation genes including PDK4 
and RASD1 were increased. Thus SSRP1 can regulate adipocyte differentiation by 
regulating the expression of key differentiation markers. However, the exact 
mechanisms how SSRP1 could affect adipocyte differentiation is broadly unknown. It 
could be possible that when SSRP1 is present it occupies the DNA in a way which 
blocks the binding of other chromatin remodelers essential for adipocyte 
differentiation, thus SSRP1 depletion facilitates the accessibility of those factors to 
chromatin resulted in an enhanced adipocyte differentiation. 
5.1.2 SSRP1 promotes osteoblast differentiation 
One major focus of this study was to find out the role of the histone chaperone 
SSRP1 in osteoblast differentiation. Osteoblast differentiation is an important 
process to establish a fine tune balance between bone formation and resorption in 
normal physiological condition where dynamic remodeling of chromatin structure is 
required for the expression or suppression of a number of genes regulating these 




processes. The role of histone chaperones in different DNA associated processes 
are well established (Song et al., 2012b). Importantly, in our study, we observed a 
significant effect on the expression of the key osteoblast differentiation marker genes 
such as ALPL, RUNX2, BGLAP and SP7 following SSRP1 depletion. This supports 
the transcriptional regulation of osteoblast differentiation specificity by SSRP1. The 
presence of SSRP1 could be essentially needed for facilitating the expression of the 
key osteoblast specific genes. Thus a loss of SSRP1 results in the deregulation of 
the expression of these genes leading to the inhibition of osteoblast differentiation. 
5.1.3 SSRP1 and transdifferentiation 
Another interesting cellular phenotype we observed from hMSC following 
SSRP1 knockdown was very elongated multinucleated cells resembles to muscle 
cells. Thus we hypothesized that transdifferenitation could be promoted in the 
absence of SSRP1. Since hMSCs are adult stem cells and having the ability to 
differentiate into a number of cell lines including muscle cells, thus it is likely that the 
cells could transdifferentiate into myoblast following SSRP1 knockdown. But our data 
regarding the gene expression studies did not further support transdifferentiation 
aspect. 
5.2 Biological processes regulated by SSRP1 
In our studies, gene ontology analyses of the transcriptome-wide RNA-seq 
data revealed various important biological processes affected by SSRP1 depletion 
during osteoblast differentiation (Table 1). These include glycoprotein/glycosylation, 
extracellular matrix and cell-cell adhesion, proteinaceous extracellular matrix, 
ossification, bone and skeletal system development etc. which have a significant 
influence during different stages of osteoblast differentiation.  
Among these, glycosylation of extracellular protein, glycoprotein and 
extracellular protein contribute to the formation of extracellular region important for 
cell-cell interaction, adhesion, maturity and  mineralization of the osteoblast 
differentiated cells (Clarke, 2008).  
The bone ECM is composed of proteins such as collagen, fibronectin, laminin, 
vitronectin, osteopontin and osteonectin (El-Amin et al., 2003). Mathews et al., (2012) 




studied the significance of some of the ECM proteins such as collagen type1, 
fibronectin, laminin and vitronectin in regulating the proliferation and osteogenic 
differentiation of the bone marrow derived hMSCs. They found the induced 
transcription of various osteoblast differentiation specific genes like ALPL following 
the treatment of ECM proteins. Overall, they showed that ECM proteins can induce 
osteoblast differentiation (Mathews et al., 2012). Studies also showed the essential 
functions of integrin in regulating osteoblast differentiation (Gronthos et al., 1997; 
Xiao et al., 2002).  
Thus, it is apparent that the cellular microenvironment is crucial for cell-cell 
interaction, adhesion, maturity and signal transduction in order to respond to different 
environmental and biochemical stimuli which collectively results in regulation of 
proliferation and differentiation of osteoblasts from the progenitor or stem cells. Any 
effect which mediates an imbalance in the expression of ECM proteins would 
significantly affect the osteoblast differentiation. Similar effects would be expected if 
changes occur in glycosylation or glycoproteins. SSRP1-mediated effects on 
different osteoblast-related important biological processes indicate the transcriptional 
siginifcance of FACT complex in regulating the expression of a large number of 
genes involved in different processes necessary for maintaining extracellular 
microenvironment and signalings. 
5.3 SSRP1 promotes osteoblast differentiation by regulating Wnt-
signaling 
The major finding of our GO analyses was the effect of SSRP1 depletion on 
Wnt-signaling (Table 1). Notably, Wnt-signaling is crucial for osteoblast 
differentiation and bone development and canonical Wnt-signaling posesses its 
potential role in bone homeostasis (Kanehisa and Goto, 2000). Moreover, non-
canonical pathways are also important during bone homeostasis. In our studies, the 
expression of number of canonical Wnt-signaling genes was inhibited following 
SSRP1 depletion. Further verification of genes including AXIN2, BMP4, DKK1, LEF1, 
LRP4, TCF7L2, WNT2, WNT11, and WISP2 in mRNA levels showed a significant 
decrease (most cases) in their expression following SSRP1 knockdown during 
osteoblast differentiation. Importantly, the effect was observed on Wnt targets (e.g., 
BMP4, WISP2), central mediators (LEF1, TCF7L2, and LRP4) and regulators (DKK1, 




WNT2, and WNT11). This finding is important since activation of Wnt-signaling plays 
a pivotal role in enhancing osteoblast differentiation and represents a potential target 
for osteoanabolic therapy (Baron and Kneissel, 2013).  
In addition, an effect on nuclear translocation of active-β-catenin following 
SSRP1 depletion and a significant co-localization of SSRP1 with active-β-catenin 
(Figure 17) suggests an inactivation of the canonical Wnt-signaling pathway 
following SSRP1 depletion. These findings indicate that SSRP1 may essentially 
interact with the transcription factors and other mediators of the Wnt signaling which 
lead to the expression of the genes necessary for osteoblast differentiation. Indeed 
canonical Wnt signaling was reported to induce key osteoblast differentiation specific 
genes including RUNX2, SP7 etc (Gaur et al., 2005; McCarthy and Centrella, 2010). 
Thus removal of SSRP1 could result in the disruption of interaction complex, led to 
the inhibition of osteoblast differentiation specific gene expressions.  
Apart from the Wnt-signaling, bone morphogenetic protein (BMP) signaling 
also plays a critical role in bone formation and skeletal development (Sanchez-
Duffhues ez al., 2015). SSRP1knockdown-mediated reduced expression of BMP4 
suggests a link between SSRP1, BMP and Wnt signaling pathways. Interestingly, the 
interaction between Wnt/β-catenin and BMP signaling during osteoblast 
differentiation and bone formation is known (Lin et al., 2011; Zhang et al., 2013). 
Moreover, Wnt/β-catenin pathway was found as an upstream of the BMP (Zhang et 
al., 2013) signaling which means that the activation of canonical Wnt-signaling could 
result in induction of BMP signaling. In contrast, BMP signaling was also found to 
stimulate Wnt/β-catenin pathway (Zhang et al., 2013). Here, we show that SSRP1 
depletion resulted in a significant decrease of a BMP signaling gene BMP4. Thereby 
we predict that SSRP1 has effects on Wnt/β-catenin pathway which in turn bring 
changes in BMP signaling pathway or vice versa. Moreover, TGF-β and Notch 
pathways also possess a positive role in osteoblast differentiation. Various studies 
also reported the interplay between Wnt, BMP, TGF-β, Notch and Hedgehog 
signaling pathways during osteoblast differentiation. Though we did not focus on 
pathways, it is possible that changes in Wnt-signaling and or BMP-signaling via 








































































































































genes PPARG and CEBPA. The role of Wnt10b in inhibiting adipocyte differentiation 
is well studied, while activated Wnt10b induced osteogenesis by blocking 
adipogenesis (Kang et al., 2007; Liu et al., 2009; Ross et al., 2000). Cawthorn et al., 
demonstrated that Wnt6 and Wnt10a as additional Wnt family members which could 
show similar effects like Wnt10b during osteoblast and adipocyte differentiation. 
Activation of Wnt10a or Wnt6a showed suppressed adipogenesis and increased 
osteogenesis (Cawthorn et al., 2012). Moreover, Wnt3a mediated stimulation also 
inhibited adipogenesis through the suppression of PPARG and CEBPA gene 
expression (Byun et al., 2014; Kawai et al., 2007; Park et al., 2015). Consistently, 
inactivation of canonical Wnt/β-catenin pathway inhibited osteoblast differentiation 
and facilitated adipocyte differentiation (Bennett et al., 2002; Laudes, 2011; Ross et 
al., 2000). Interestingly, loss of β-catenin function from preosteoblasts behaved as a 
switch for changing osteoblasts to adipocytes (Song et al., 2012a). Furthermore, the 
transcription factor PPARG is a prime inducer of adipogenesis that inhibits 
osteogenesis. When adipocyte differentiation was prompted by CEBPB and PPARG 
there was an extensive downregulation of the nulear β-catenin which suggest a 
CEBPB and PPARG mediated control on canonical Wnt-signaling that blocks 
osteogenesis (Moldes et al., 2003). Overall, these observations clearly show a 
reciprocal regulation between adipocyte and osteoblast fate deteremination. SSRP1 
mediated regulation on Wnt signaling and BMP signaling pathways can significantly 
control this reciprocal relationship where the presense of SSRP1 promotes 
osteoblast differentiation over adipocyte differentiation.  
5.4.2 Chromatin-associated aspects 
Transcription is highly assisted by alterations in the chromatin structure so 
that it becomes more accessible for different molecular machineries essential to 
mediate cellular differentiation and proliferation. Thus, reorganization of chromatin by 
histone chaperone SSRP1 may be essential for facilitating gene expression including 
the key osteoblast differentiation-specific genes as well as Wnt-signaling and target 
genes which promotes osteoblast differentiation and suppresses adipocyte 
differentiation. More importantly, specificity of the histone chaperones and other 
chromatin remodelers could also be a limiting point for cellular fate decision 





























































































































The spatial and temporal binding of histone chaperones to the chromatin may 
also determine the cell fate decision depending on cellular and environmental stimuli 
as well as local and global arrangement of the chromatin. We checked the available 
SSRP1 occupancy and observed that some osteoblast differentiation marker genes 
possess binding of SSRP1 on the transcribed regions whereas Wnt signaling genes 
show SSRP1 occupancy from transcribed region to transcription termination sites 
(data not shown). Importantly for adipocyte differentiation, formation of early and late 
enhancer complexes along with transcription factors C/EBPB/D, GR, STAT5A (early 
enhancer complex); PPARG:RXR, CEBPA (late enhancer complex) are very crucial 
for the activation of PPARG promoter and subsequent activation of other 
downstream gene expression (Siersbæk et al., 2012). We did not find SSRP1 
occupancy in the enhancer region of these key adipocyte differentiation specific 
genes (data not shown). This could suggest that the direct transcriptional role of 
SSRP1 could be implemented on osteoblast-specific genes. The lack of SSRP1 
occupancy in the enhancer regions of the important adipocyte differentiation specific 
genes indicate that absence of SSRP1 might be necessary for adipocyte 
differentiation. 
5.5 Translational significance of this study  
Initially FACT complex was thought as a ubiquitously expressed 
housekeeping factor which is not associated with any disease (Singer and Johnston, 
2004). However, recently higher expression of FACT complex was found to be 
associated with undifferentiated, stem cells or stem cell-like cells and poorly 
differentiated aggressive cancer (Gasparian et al., 2011; Koman et al., 2012; Garcia 
et al., 2013). Importantly FACT complex was found to be highly expressed in a 
number of tumor types including breast, gastrointestinal neoplasms, colorectal 
neoplasms, intestinal and digestive system neoplasms and osteosarcoma. Notably, 
there is an inhibitor available for FACT called Curaxin or CBL0137 which is currently 
in Phase I trial and showed to possess potential effect on glioblastoma, 
neuroblastoma, pancreatic cancer, Her2/neu positive mammary carcinomas 
(Dermawan et al., 2016; Carter et al., 2015; Burkhart et al., 2014;  Koman et al., 
2012). 




Our findings provide an important insight into the molecular function of the 
histone chaperone SSRP1 during osteoblast differentiation by controlling the Wnt 
signaling pathway and exhibiting a fine-tune over cell fate determination and lineage-
specific differentiation. Thus SSRP1 could be a potential target for treating cancers 
where FACT complex is highly expressed. Moreover, a number of diseases including 
colorectal cancer and age related bone loss shows dysregulated Wnt signaling 
pathway which can also be targeted for treatment through inhibition of SSRP1. 
Interestingly both of the FACT components were found to be higher in colorectal 
cancer cells (data not shown). Furthermore osteosarcoma is a bone related 
childhood cancer with highly proliferative undifferentiated or less differentiated 
malignant cells where osteoblast-specific genes expression is also disrupted. SSRP1 
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